Log In
Print this Print this

KamRho-D IV

  Manage Alerts
Collapse Summary General Information
Company Kamada Ltd.
DescriptionHuman Anti-D (Rho) immunoglobulin for intravenous administration
Molecular Target Rh factor
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationIdiopathic thrombocytopenic purpura (ITP)
Indication DetailsTreat idiopathic thrombocytopenic purpura (ITP)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today